Cross reactivity between IA-2 and phogrin/IA-2 beta in binding of autoantibodies in IDDM

被引:29
作者
Hatfield, ECI [1 ]
Hawkes, CJ [1 ]
Payton, MA [1 ]
Christie, MR [1 ]
机构
[1] UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT MED,LONDON SE5 9PJ,ENGLAND
基金
英国惠康基金;
关键词
autoantibodies; autoantigens; tyrosine phosphatase; epitopes; insulin-dependent diabetes;
D O I
10.1007/s001250050828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with insulin-dependent diabetes mellitus (IDDM) possess antibodies to the cytoplasmic domains of two closely related tyrosine phosphatase-like proteins, IA-2 and phogrin, previously detected as 40 kDa and 37 kDa tryptic fragments, respectively. A higher proportion of IDDM patients possess antibodies to IA-2 than to phogrin, and autoimmunity to phogrin might arise through cross-reactivity with the highly homologous IA-2. In this study, we have investigated the major regions of IA-2 recognized by antibodies in IDDM patients and examined the ability of phogrin to block antibody binding to these regions as a measure of cross-reactivity. Analysis of antibody binding to in vitro transcribed and translated polypeptides representing different regions of the cytoplasmic domain of IA-2 identified five different patterns of reactivity with antibodies in IDDM. Protein footprinting analysis, whereby polypeptide fragments generated on protease treatment of immune complexes are studied, indicated considerable heterogeneity in antibody recognition of IA-2, even between sera with similar reactivity to deletion mutants. Blocking studies with recombinant phogrin indicated that IA-2 antibodies recognize epitopes that are both unique to IA-2 and shared with phogrin. The amino-terminal 150 amino acids of the cytoplasmic domain of IA-2 encompass epitopes that are not represented on phogrin, whereas shared epitopes are localized within the carboxy-terminal 220 amino acids. The results demonstrate considerable heterogeneity between IDDM patients in autoantibody recognition of IA-2 in IDDM, whereas antibody recognition of phogrin is restricted in most patients to epitopes also present on IA-2.
引用
收藏
页码:1327 / 1333
页数:7
相关论文
共 19 条
[11]  
Lai M., 1997, Diabetologia, V40, pA76
[12]  
Lampasona V, 1996, J IMMUNOL, V157, P2707
[13]   MOLECULAR-CLONING AND IDENTIFICATION OF A RECEPTOR-TYPE PROTEIN-TYROSINE-PHOSPHATASE, IA-2, FROM HUMAN INSULINOMA [J].
LAN, MS ;
LU, J ;
GOTO, Y ;
NOTKINS, AL .
DNA AND CELL BIOLOGY, 1994, 13 (05) :505-514
[14]   Identification of a second transmembrane protein tyrosine phosphatase, IA-2 beta, as an autoantigen in insulin-dependent diabetes mellitus: Precursor of the 37-kDa tryptic fragment [J].
Lu, J ;
Li, Q ;
Xie, H ;
Chen, ZJ ;
Borovitskaya, AE ;
Maclaren, NK ;
Notkins, AL ;
Lan, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) :2307-2311
[15]   THE 37/40-KILODALTON AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES-MELLITUS IS THE PUTATIVE TYROSINE PHOSPHATASE IA-2 [J].
PASSINI, N ;
LARIGAN, JD ;
GENOVESE, S ;
APPELLA, E ;
SINIGAGLIA, F ;
ROGGE, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9412-9416
[16]   RELATIONSHIP OF THE 37,000-M(R) AND 40,000-M(R) TRYPTIC FRAGMENTS OF ISLET ANTIGENS IN INSULIN-DEPENDENT DIABETES TO THE PROTEIN-TYROSINE PHOSPHATASE-LIKE MOLECULE IA-2 (ICA512) [J].
PAYTON, MA ;
HAWKES, CJ ;
CHRISTIE, MR .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1506-1511
[17]   PROTEIN ANTIGEN MONOCLONAL-ANTIBODY CONTACT SITES INVESTIGATED BY LIMITED PROTEOLYSIS OF MONOCLONAL ANTIBODY-BOUND ANTIGEN - PROTEIN FOOTPRINTING [J].
SHESHBERADARAN, H ;
PAYNE, LG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (01) :1-5
[18]   Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes [J].
Wasmeier, C ;
Hutton, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :18161-18170
[19]   Autoantibodies to IA-2 in IDDM - Location of major antigenic determinants [J].
Zhang, BW ;
Lan, MS ;
Notkins, AL .
DIABETES, 1997, 46 (01) :40-43